Evaluating Anemia Care Pathways to Assess and Manage Iron-Deficiency and Anemia in Patients with IBD: Meet Jim
GastroenterologyOvercoming Missed Opportunities in the Management of Concurrent Anemia in Adult Patients with IBD
0.50 AMA PRA Category 1 Credit(s) ™
November 22, 2019
The accreditation for this activity has expired.
Primary Audience:
gastroenterologists, internal medicine physicians, family medicine physicians, nurse practitioners, and physician assistants
Relevant Terms:
inflammatory bowel disease, ulcerative colitis, Crohn’s disease, iron-deficiency anemia, anemia, anemia care pathways
Gary R. Lichtenstein, MD
Professor of Medicine
Director, Center for Inflammatory Bowel Diseases
The Raymond and Ruth Perelman School of Medicine of the University of Pennsylvania
Hospital of the University of Pennsylvania
Gastroenterology Division, Department of Internal Medicine
Perelman Center for Advanced Medicine
Philadelphia, PA
Gary R. Lichtenstein, MD, FACP, FACG, AGAF is the Director of the Inflammatory Bowel Disease Center and a Professor of Medicine in the Gastrointestinal Division of the Department of Medicine at the Hospital of the University of Pennsylvania and the University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania. Dr. Lichtenstein earned his medical degree from the Mount Sinai School of Medicine, in New York, New York. He then completed his internship and residency in Internal Medicine at Duke University Medical Center, in Durham, North Carolina. He also served a fellowship in Gastroenterology at the Hospital of the University of Pennsylvania of the University Of Pennsylvania School Of Medicine. His current research interests encompass investigational therapies for the treatment of ulcerative colitis and Crohn’s disease as well his research has had a significant focus on the safety of current and future medical therapy. He has also focused his research on the natural history of disease. Dr. Lichtenstein has received numerous research grants focusing on these areas and has served as the national/ international principal investigator evaluating novel agents for therapeutic trials in the treatment of Ulcerative Colitis and Crohn’s disease.
A Fellow of the American Gastroenterological Association, the American College of Physicians and the American College of Gastroenterology, Dr. Lichtenstein has been listed in “Best Doctors in America” (inflammatory bowel disease), and has served as Medical Secretary for the American Board of Internal Medicine, Gastroenterology Section. He holds membership and committee positions in many professional societies at a national level, including the American Gastroenterological Association where he has served as the vice-chair of the clinical practice committee and practice economics committee and where he has served as chair of the clinical practice committee, the American Society for Gastrointestinal Endoscopy where he has served on the committee on training, the American College of Gastroenterology where he has served on the Education Committee, Programs Committee and the Nominations Committee. He recently served as a member of the research committee. He has been the chair of the abstract review committee for Inflammatory Bowel Disease for the American College of Gastroenterology. He is also a member of the Crohn’s and Colitis Foundation of America where he served at the national level as the chair of the membership committee of the Clinical Research Alliance, he has served on the national grants review committee and the national physician education committee. He additionally is a longstanding member of the American College of Physicians and the American Medical Association.
Dr. Lichtenstein has received numerous awards including the National Scientific Achievement Award from the national Crohn’s and Colitis Foundation of America (CCFA) for his clinical work and research. He has received the award for the top specialist in the University of Pennsylvania Health system- the Louis A. Duhring Award. He is the recipient of the Christina and Marie Lindback award- the top teaching award in the entire University of Pennsylvania. He has received the medical school teaching award the "Penn Pearls Award". He has received the Department of Medicine house staff teaching award- the "Donald B. Martin Teaching Award". He has received the Gastroenterology Division teaching award - the Sidney Cohen Teaching Award. He is listed in “The Best Doctors in America” - Inflammatory Bowel Disease and in Philadelphia Magazine-Listed among top Gastroenterologists for elderly in Philadelphia and Listed among top Gastroenterologists in Philadelphia (Special Focus: Inflammatory Bowel Disease). He is the recipient of the CCFA- Physician of the Year Award: Philadelphia and Delaware Valley Chapters.
In addition to having served on the Editorial Board of the journals Gastroenterology, American Journal of Gastroenterology, Inflammatory Bowel Diseases, World Journal of Gastroenterology, and Digestive Diseases and Sciences Dr. Lichtenstein currently serves as the IBD Associate Editor for the American Journal of Gastroenterology and also has served as a former writer of Selected Summaries in the journal Gastroenterology and served as the section editor of Selected Summaries and the section editor of Print and Media Review in Gastroenterology for a 5 year term. He also has and currently serves as a reviewer for such journals as The New England Journal of Medicine, Gastroenterology, The Lancet, the Annals of Internal Medicine, Clinical Gastroenterology and hepatology, Gut, Journal of Parenteral and Enteral Nutrition, the American Journal of Gastroenterology, the World Journal of Gastroenterology and the Journal of Clinical Gastroenterology. He is the executive editor and founder of a PubMed indexed journal Gastroenterology and Hepatology and has served as Associate editor of Therapeutic Advances in Gastroenterology, The Physician and Sports medicine, Clinical Investigation, and has served as Assistant Editor-in-Chief of the World Journal of Gastroenterology. An invited lecturer at the local, national, and international levels, Dr. Lichtenstein is the author or coauthor of more than 325 peer-reviewed primary articles and chapters, and he has presented over 250 abstracts and edited 18 books. He has lectured at a national and an international level at over 500 invited conferences, lectures, symposiums and institutional grand rounds.
Michael D. Cirigliano, MD, FACP
Founder's Associate Professor of General Internal Medicine
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, PA
Dr. Cirigliano is an Associate Professor of Medicine and practicing Internist at the Perelman School of Medicine at the University of Pennsylvania. He has over sixty publications in the medical literature and has been published in journals including the Journal of the American Medical Association, Hospital Practice and the Journal of Women’s Health. He has lectured throughout the country and has served on the editorial board of the Facts and Comparisons publication Review of Natural Products, and Hospital Physician. Dr. Cirigliano practices Internal Medicine full time and treats a full range of medical disorders in the adult patient population.
Dr. Cirigliano currently serves as the medical correspondent and on air personality for the FOX 29 News program “Good Day Philadelphia.” He has also been on the Dr Oz show and the Montel Williams show. Over the years, “Dr. Mike” has covered innumerable medical topics including sports injuries to infectious disease. He has a special interest in prevention and healthy living.
Dr. Cirigliano was featured in Philadelphia Magazine’s “Top Docs” issue every year since 1996. He was also recognized by the Castle Connelly publication “Best Doctors In America” every year since 2008.
Dr. Cirigliano was born and raised in the Philadelphia area. He is married and has two children, Amy and Nicholas. His interests include aviation and ice hockey. He is a terrible hockey player.
| 1. | Describe the factors that contribute to the development of anemia in adult patients with IBD | 2. | Identify the signs and symptoms of anemia and describe the impact on adult patients with IBD. |
| 3. | Assess strategies to treat iron-deficiency anemia and anemia of chronic disease in adult patients with IBD to optimize IBD treatment and improve quality of life. | 4. | Evaluate how an anemia care pathway can be incorporated into practice to improve screening, evaluation, treatment and follow-up care of anemia in adult patients with IBD. |
| 1. | Describe the factors that contribute to the development of anemia in adult patients with IBD |
| 2. | Identify the signs and symptoms of anemia and describe the impact on adult patients with IBD. |
| 3. | Assess strategies to treat iron-deficiency anemia and anemia of chronic disease in adult patients with IBD to optimize IBD treatment and improve quality of life. |
| 4. | Evaluate how an anemia care pathway can be incorporated into practice to improve screening, evaluation, treatment and follow-up care of anemia in adult patients with IBD. |
Activity Description
Anemia associated with iron deficiency and disease activity is the most common complication in patients with IBD and leads to reduced quality of life and increased healthcare resource use. Despite published practice guidelines and quality measures for anemia in IBD, screening and management of anemia among IBD patients is suboptimal.
Using clinical case scenarios, this activity (second in the series) will improve learners’ knowledge and competence regarding the
- Recognition and significance of anemia in general and in adult patients with IBD
- Impact of anemia on the quality of life of patients with IBD
- Significance of anemia as an indicator of disease activity
- Anemia care pathways and the need for actively supported anemia treatment with different IBD regimens
Target Audience
This curriculum will be designed to meet the educational needs of gastroenterologists, internal medicine physicians, family medicine physicians, gastroenterology fellows, nurse practitioners, and physician assistants involved in the care and treatment of adult patients with IBD.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Describe the factors that contribute to the development of anemia in adult patients with IBD.
- Identify the signs and symptoms of anemia and describe the impact on adult patients with IBD.
- Assess strategies to treat iron-deficiency anemia and anemia of chronic disease in adult patients with IBD to optimize IBD treatment and improve quality of life.
- Evaluate how an anemia care pathway can be incorporated into practice to improve screening, evaluation, treatment and follow-up care of anemia in adult patients with IBD.
Criteria for Success
Statements of credit will be awarded based on the participant reviewing each presentation, scoring a 70% on the post test, and completing and submitting an activity evaluation. A statement of credit will be available upon completion of an online evaluation/claimed credit form. You must participate in the entire activity to receive credit. There is no fee to participant in this activity. If you have questions about this CME activity, please contact AKH Inc. at tbrignoni@akhcme.com.
CME Credit provided by AKH Inc., Advancing Knowledge in Healthcare
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and peerXchange Inc. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
Faculty Disclosures
Michael D. Cirigliano, MD, FACP, discloses no financial relationships with pharmaceutical or medical product manufacturers.
Gary R. Lichtenstein, MD, has disclosed the following relevant financial relationships:
Consultant - Abbvie, American Regent / Luitpold, Celgene, CellCeutrix, Eli Lilly, Ferring, Gilead, Janssen Orthobiotech (Funding to University of PA - IBD Fellow Education), Pfizer Pharmaceuticals (Funding to University of PA - IBD Fellow Education), Prometheus Laboratories, Inc., Romark, Salix Pharmaceuticals/Valeant, Shire Pharmaceuticals, Takeda (Funding to University of PA - IBD Fellow Education), UCB
Contracted Research - Celgene, Janssen Orthobiotech (Funding to University of PA - IBD Fellow Education), Salix Pharmaceuticals/Valeant, Shire Pharmaceuticals, UCB
Other - American College of Gastroenterology (Honorarium for Associate Editor of American Journal of Gastroenterology), American Regent / Luitpold (CME Program Support) Clinical Advances in Gastroenterology Editor, Eli Lilly (Data Safety Monitoring Board), Gastroenterology and Hepatology (Gastro-Hep Communications) - Editor (Honorarium), McMahon Publishing- Author (Honorarium), Merck (Honorarium for CME Program), Romark (Honorarium for CME Program), SLACK, Inc (Book Royalty), Springer Science and Business Media Editor (Honorarium), Up-To-Date- Author (Honorarium)
Staff and Reviewers Disclosures
Dorothy Caputo, MA, BSN, RN, Lead Nurse Planner/Reviewer, discloses no financial relationships with pharmaceutical or medical product manufacturers.
Patricia Brignoni, AKH Director of Operations/Reviewer, discloses no financial relationships with pharmaceutical or medical product manufacturers.
Wendy Gloffke, PhD, Medical Writer, discloses no financial relationships with pharmaceutical or medical product manufacturers.
AKH Inc. and peerXchange Inc. planners and reviewers have no relevant financial relationships to disclose.
Commercial Support
This activity is supported by an independent educational grant from Pfizer Inc.
Disclosure Declaration
It is the policy of AKH Inc. and peerXchange Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. and peerXchange Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Required Hardware/Software
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.
Copyright 2019 peerXchange, Inc. No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publisher.
AKH Inc. Privacy Policy
Continuing Medical Education and Continuing Education
When you register for a Continuing Medical Education (CME) or a Continuing Education (CE) activity through one of our Web sites, we collect certain personally identifiable information from you such as your name, email address and mailing address. If you are a pharmacist and wish to receive CE credit, you are also required to provide your NAPB # and month and day of birth. For more information about NABP and CPE Monitor click here. In addition to personally identifiable information, we collect aggregated non-personally identifiable information about the activities undertaken by our users. We use the information that we collect through CME/CE activities in several ways:
- We work with several accredited companies who are accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. As a joint-provider, we are required periodically to submit aggregated data about CME participants and the CME activities we certify. We also provide personally identifiable information to other accredited CME/CE providers who certify CME/CE activities posted on our Web sites, as required by the ACCME and other accrediting bodies. These reports may include personally identifiable information about you and credits issued to you, for the purpose of maintaining records that you can request from the accredited provider for up to six (6) years;
- Commercial supporters of CME/CE activities on our Web site will receive only aggregated data about CME/CE activities that are relevant to their interests and/or the courses they support;
- Our Editorial and Customer Support Staff will have internal access to files containing personally identifiable information, including evaluation forms and aggregated CME /CE participant information. These files can be accessed in order to respond to your questions or comments. Our staff may also use personally identifiable information, including registration information and evaluation data, in assessing educational needs and planning marketing activities.
We may use the information we collect as otherwise permitted in this Privacy Policy.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
